PMC:7784786 / 663-762 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7784786","sourcedb":"PMC","sourceid":"7784786","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7784786","text":"anded access protocol. Itolizumab was able to reduce IL-6 concentrations in all the patients. Two o","tracks":[{"project":"LitCovid-PubTator","denotations":[{"id":"28","span":{"begin":53,"end":57},"obj":"Gene"},{"id":"31","span":{"begin":84,"end":92},"obj":"Species"},{"id":"35","span":{"begin":23,"end":33},"obj":"Chemical"}],"attributes":[{"id":"A28","pred":"tao:has_database_id","subj":"28","obj":"Gene:3569"},{"id":"A31","pred":"tao:has_database_id","subj":"31","obj":"Tax:9606"},{"id":"A35","pred":"tao:has_database_id","subj":"35","obj":"MESH:C000597346"},{"subj":"28","pred":"source","obj":"LitCovid-PubTator"},{"subj":"31","pred":"source","obj":"LitCovid-PubTator"},{"subj":"35","pred":"source","obj":"LitCovid-PubTator"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}]},{"project":"LitCovid-sentences","denotations":[{"id":"T8","span":{"begin":23,"end":93},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T8","pred":"source","obj":"LitCovid-sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PubTator","color":"#cf93ec","default":true},{"id":"LitCovid-sentences","color":"#93ecb5"}]}]}}